clotrimazole has been researched along with Atherogenesis in 1 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| " Therapeutic concentrations of TRAM-34 in mice caused no discernible toxicity after repeated dosing and did not compromise the immune response to influenza virus." | 1.35 | The intermediate-conductance calcium-activated potassium channel KCa3.1 contributes to atherogenesis in mice and humans. ( Azam, P; Chandy, KG; Das, S; Fujiwara, Y; Gutterman, DD; Harder, DR; Hatoum, OA; Mattson, DL; Melvin, JE; Miura, H; Pratt, PF; Raman, G; Saito, T; Toyama, K; Wulff, H, 2008) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Toyama, K | 1 |
| Wulff, H | 1 |
| Chandy, KG | 1 |
| Azam, P | 1 |
| Raman, G | 1 |
| Saito, T | 1 |
| Fujiwara, Y | 1 |
| Mattson, DL | 1 |
| Das, S | 1 |
| Melvin, JE | 1 |
| Pratt, PF | 1 |
| Hatoum, OA | 1 |
| Gutterman, DD | 1 |
| Harder, DR | 1 |
| Miura, H | 1 |
1 other study available for clotrimazole and Atherogenesis
| Article | Year |
|---|---|
The intermediate-conductance calcium-activated potassium channel KCa3.1 contributes to atherogenesis in mice and humans.
Topics: Animals; Aorta; Atherosclerosis; Clotrimazole; Humans; Intermediate-Conductance Calcium-Activated Po | 2008 |